Home > Insider Trading > Filing (0000950142-16-004306)

Filing Details

Accession Number:: 0000950142-16-004306
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-12 16:10:48
Reporting Period:: 2016-08-11

Filing Date:: 2016-08-12
Accepted Time:: 2016-08-12 16:10:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1415336	Zeltiq Aesthetics Inc	ZLTQ	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1172252	N Andrew Schiff	888 Seventh Avenue 12Th Floor New York NY 10106		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-08-11	269,231	$36.37	1,828,511	No	4	S	Indirect	By Aisling Capital III, L.P.
Common Stock	Disposition	2016-08-11	230,769	$36.42	1,597,742	No	4	S	Indirect	By Aisling Capital III, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Aisling Capital III, L.P.
No	4	S	Indirect	By Aisling Capital III, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	13,137	Direct

Footnotes

Consists of 7,455 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock") and 5,682 restricted stock units. Each restricted stock unit represents a contingent right to receive one share. The restricted stock units vest in 12 ratable monthly installments on the 16th of each month, beginning on July 16, 2016, subject to Mr. Schiff's continued service with the Issuer, and upon vesting Mr. Schiff receives shares of Common Stock. Such shares of Common Stock include 87 shares of Common Stock held by a trust for the benefit of Mr. Schiff's children.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.22 to $38.05, inclusive. The reporting person undertakes to provide to Zeltiq Aesthetics Inc, any security holder of Zeltiq Aesthetics Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
The shares of Common Stock are directly held by Aisling Capital III, LP ("Aisling") and are indirectly held by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III, LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners, and the Managers share voting and dispositive power over the shares directly held by Aisling. Dr. Andrew Schiff is a member of the Board of Directors of Zeltiq Aesthetics, Inc.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.850 to $36.865, inclusive. The reporting person undertakes to provide to Zeltiq Aesthetics Inc, any security holder of Zeltiq Aesthetics Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.